CLINICAL_TRIALS
trial_result
· 2020-10-08
Clinical Trial Update: Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women [Phase 3]
Summary
Phase 3 trial evaluating EN3835 for cellulite in women has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Edematous Fibrosclerotic Panniculopathy (Cellulite) | Phase 3 | Status: COMPLETED | Results posted: 2020-10-08